Addiction Medicine
Conference Coverage
Survey reveals room for improvement in teen substance use screening
Lack of treatment and referral options impedes routine substance use screening in primary care settings.
From the Journals
Why is buprenorphine use flatlining?
“Clinicians are not maximizing opportunities to initiate buprenorphine treatment among patients with opioid addiction,” Dr. Kao-Ping Chua said.
Latest News
You’ve quit smoking with vaping. Now what?
People who vape may have a higher level of nicotine addiction.
Latest News
What will vaping lead to? Emerging research shows damage, and addiction
Vaping may worsen bronchitis and asthma, raise blood pressure, and interfere with brain development in young users.
Feature
Should you recommend e-cigs to help patients quit smoking?
“There is scientific research to support vaping as a cessation tool, but we wouldn’t use it as a first line of defense because we still need...
Latest News
Integrating addiction medicine with primary care cost effective: Study
Compared with the status quo, integrating buprenorphine and harm reduction kits reduced drug use–related deaths by 33% and was cost effective,...
From the Journals
New insight into the growing problem of gaming disorder
Massively multiplayer online role-playing games, first-person/third-person shooter games, real-time strategy games, and multiplayer online battle...
Guidelines
New guidelines for cannabis in chronic pain management released
New clinical practice guidelines for cannabis in chronic pain management may help clinicians offer an effective and less addictive alternative to...
Latest News
Is vaping a gateway to cigarettes for kids?
The percentage of adolescents who move on to smoking after starting to vape remains low, and those who do start smoking are unlikely to continue...
From the Journals
Telehealth services tied to a major reduction in opioid overdose deaths
“The expansion of telehealth during the COVID-19 pandemic appears to have had positive effects on patients receiving MOUD [medication for opioid...
Latest News
Tranq-contaminated fentanyl now in 48 states, DEA warns
Xylazine was first approved by the FDA in 1972 as a sedative and analgesic for use only in animals, but is increasingly being detected in illicit...